Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -225.20% | -7.04% | -7.04% | -7.04% | 174.21% |
| Total Depreciation and Amortization | 34.91% | -40.36% | -40.36% | -40.36% | -609.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.50% | 119.57% | 119.57% | 119.57% | -17,084.62% |
| Change in Net Operating Assets | -70.05% | 79.28% | 79.28% | 79.28% | 331.91% |
| Cash from Operations | -63.16% | 6.83% | 6.83% | 6.83% | 44.57% |
| Capital Expenditure | -20.90% | 49.60% | 49.60% | 49.60% | 51.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.89% | 117.85% | 117.85% | 117.85% | 160.62% |
| Cash from Investing | 185.72% | 111.53% | 111.53% | 111.53% | 133.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | 16.49% | 16.49% | 16.49% | -32.14% |
| Issuance of Common Stock | -90.91% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.00% | 16.49% | 16.49% | 16.49% | -19.05% |
| Foreign Exchange rate Adjustments | -242.35% | -429.37% | -429.37% | -429.37% | 257.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.00% | 85.09% | 85.09% | 85.09% | 112.20% |